Upper limb fracture
Conditions
Interventions
experimental group:The inpatient perioperative treatment of homogenization of clinical pathway of department dominant diseases was adopted. One week after operation, Bugu capsule (prepared in our hosp
control group:The inpatient perioperative treatment with homogenization of clinical pathway of department dominant diseases was adopted. Calcium carbonate (Caltrate D, Wyeth pharmaceutical, h10950030)
Sponsors
Chongqing orthopedic hospital of traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1) The patient met the diagnosis of traumatic upper limb fracture in western medicine and fracture disease of qi stagnation and blood stasis type in traditional Chinese medicine; 2) The patients were informed and voluntarily joined the study; 3) The patients could be treated with internal fixation and oral Bugu capsules.
Exclusion criteria
Exclusion criteria: 1) Patients with multiple fractures of the upper extremity were excluded; 2) Patients with old fracture of upper limb were excluded; 3) Exclude pregnant and lactating female patients; 4) Patients with organ dysfunction were excluded; 5) Excluding patients with malignant tumors; 6) Patients with pathological fractures of the upper extremity were excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical healing time of fracture;Clinical efficiency;TCM symptom score; | — |
Secondary
| Measure | Time frame |
|---|---|
| Upper limb dysfunction rating scale score;Changes in bone metabolites;Fugl Meyer motor function score; | — |
Countries
China
Contacts
Public ContactQI Guodong
Chongqing orthopedic hospital of traditional Chinese Medicine
Outcome results
None listed